Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2015 Dec;5(2):020415.
doi: 10.7189/jogh.05.020415.

Global and regional estimates of COPD prevalence: Systematic review and meta-analysis

Davies Adeloye  1 , Stephen Chua  1 , Chinwei Lee  1 , Catriona Basquill  1 , Angeliki Papana  1 , Evropi Theodoratou  1 , Harish Nair  1 , Danijela Gasevic  1 , Devi Sridhar  1 , Harry Campbell  1 , Kit Yee Chan  1 , Aziz Sheikh  1 , Igor Rudan  1 ; Global Health Epidemiology Reference Group (GHERG)
Affiliations
Meta-Analysis

Global and regional estimates of COPD prevalence: Systematic review and meta-analysis

Davies Adeloye et al. J Glob Health. 2015 Dec.

Abstract

Background: The burden of chronic obstructive pulmonary disease (COPD) across many world regions is high. We aim to estimate COPD prevalence and number of disease cases for the years 1990 and 2010 across world regions based on the best available evidence in publicly accessible scientific databases.

Methods: We conducted a systematic search of Medline, EMBASE and Global Health for original, population-based studies providing spirometry-based prevalence rates of COPD across the world from January 1990 to December 2014. Random effects meta-analysis was conducted on extracted crude prevalence rates of COPD, with overall summaries of the meta-estimates (and confidence intervals) reported separately for World Health Organization (WHO) regions, the World Bank's income categories and settings (urban and rural). We developed a meta-regression epidemiological model that we used to estimate the prevalence of COPD in people aged 30 years or more.

Findings: Our search returned 37 472 publications. A total of 123 studies based on a spirometry-defined prevalence were retained for the review. From the meta-regression epidemiological model, we estimated about 227.3 million COPD cases in the year 1990 among people aged 30 years or more, corresponding to a global prevalence of 10.7% (95% confidence interval (CI) 7.3%-14.0%) in this age group. The number of COPD cases increased to 384 million in 2010, with a global prevalence of 11.7% (8.4%-15.0%). This increase of 68.9% was mainly driven by global demographic changes. Across WHO regions, the highest prevalence was estimated in the Americas (13.3% in 1990 and 15.2% in 2010), and the lowest in South East Asia (7.9% in 1990 and 9.7% in 2010). The percentage increase in COPD cases between 1990 and 2010 was the highest in the Eastern Mediterranean region (118.7%), followed by the African region (102.1%), while the European region recorded the lowest increase (22.5%). In 1990, we estimated about 120.9 million COPD cases among urban dwellers (prevalence of 13.2%) and 106.3 million cases among rural dwellers (prevalence of 8.8%). In 2010, there were more than 230 million COPD cases among urban dwellers (prevalence of 13.6%) and 153.7 million among rural dwellers (prevalence of 9.7%). The overall prevalence in men aged 30 years or more was 14.3% (95% CI 13.3%-15.3%) compared to 7.6% (95% CI 7.0%-8.2%) in women.

Conclusions: Our findings suggest a high and growing prevalence of COPD, both globally and regionally. There is a paucity of studies in Africa, South East Asia and the Eastern Mediterranean region. There is a need for governments, policy makers and international organizations to consider strengthening collaborations to address COPD globally.

PubMed Disclaimer

Figures

Figure 1
Figure 1
PRISMA flowchart of study selection.
Figure 2
Figure 2
Overall pooled crude prevalence of COPD by WHO regions.
Figure 3
Figure 3
Overall pooled crude prevalence of COPD by study settings.
Figure 4
Figure 4
Overall pooled crude prevalence of COPD by World Bank income category.
Figure 5
Figure 5
Epidemiological model based on meta–regression: The model is based on extracted crude COPD prevalence rates and adjusted for the study period and mean age of subjects from each study (the size of each bubble corresponds to the sample size from the respective study).
See this image and copyright information in PMC

Comment in

References

    1. Beaglehole R, Bonita R, Alleyne G, Horton R, Li L, Lincoln P, et al. UN High–Level Meeting on Non–Communicable Diseases: addressing four questions. Lancet. 2011;378:449–55. doi: 10.1016/S0140-6736(11)60879-9. - DOI - PubMed
    1. Horton R. Non–communicable diseases: 2015 to 2025. Lancet. 2013;381:509–10. doi: 10.1016/S0140-6736(13)60100-2. - DOI - PubMed
    1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370:765–73. doi: 10.1016/S0140-6736(07)61380-4. - DOI - PubMed
    1. Barnes PJ. Chronic Obstructive Pulmonary Disease: A growing but neglected global epidemic. PLoS Med. 2007;4:e112. doi: 10.1371/journal.pmed.0040112. - DOI - PMC - PubMed
    1. World Health Organization. Global Burden of Disease (GBD) 2002 estimates. In: World Health Report 2004. Geneva: WHO, 2004. Available: http://www.who.int/healthinfo/global_burden_disease/estimates_regional_2.... Accessed: 25 November 2015.